Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report

BACKGROUND: Collecting duct carcinoma (CDC) of the kidney is a rare and highly aggressive malignant tumor with the worst prognosis among all renal cancers. Nevertheless, the first-line treatments, including chemotherapy and target therapy, usually show poor response to CDC. Recent studies have sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yongyi, Zhang, Wei, Li, Zhenli, Zheng, Youshi, Wang, Yingchao, Chen, Geng, Qiu, Liman, Ke, Kun, Su, Xiaoping, Cai, Zhixiong, Liu, Jingfeng, Liu, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247377/
https://www.ncbi.nlm.nih.gov/pubmed/32439798
http://dx.doi.org/10.1136/jitc-2019-000217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247377/
https://www.ncbi.nlm.nih.gov/pubmed/32439798
http://dx.doi.org/10.1136/jitc-2019-000217

Ejemplares similares